Gelfond, Jonathan
The University of Texas at San Antonio Health Science Center
5 papers on CoChatORCID 0000-0002-0773-3683
Most cited papers
- Verified
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
Nambiar, A., Kellogg, D., Justice, J., Goros, M., Gelfond, J., Pascual, R., Hashmi, S., Masternak, M., Prata, L., LeBrasseur, N., et al. (2023) · eBioMedicine
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisTelomeres, Telomerase, and Senescence
Cited by 298
- Verified
Fat maintenance is a predictor of the murine lifespan response to dietary restriction
Liao, C., Rikke, B. A., Johnson, T. E., Gelfond, J. A. L., Diaz, V., & Nelson, J. F. (2011) · Aging Cell
Genetics, Aging, and Longevity in Model OrganismsDietary Effects on Health
Cited by 120
- Verified
Clinical efficacy of nanohydroxyapatite-containing toothpaste at relieving dentin hypersensitivity: an 8 weeks randomized control trial
Amaechi, B. T., Lemke, K. C., Saha, S., Luong, M. N., & Gelfond, J. (2021) · BDJ Open
Dental Erosion and TreatmentDental Health and Care Utilization
Cited by 48
- Verified
Methods for training collaborative biostatisticians
Pomann, G.-M., Boulware, L. E., Cayetano, S. M., Desai, M., Enders, F. T., Gallis, J. A., Gelfond, J., Grambow, S. C., Hanlon, A. L., Hendrix, A., et al. (2021) · Journal of Clinical and Translational Science
Interdisciplinary Research and CollaborationHealth and Medical Research Impacts
Cited by 32
- Verified
Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial
Gelfond, J., Al-Bayati, O., Kabra, A., Iffrig, K., Kaushik, D., & Liss, M. A. (2018) · Urologic Oncology: Seminars and Original Investigations
Renal cell carcinoma treatmentCancer Risks and Factors
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free